Genesys International Corp Intrinsic Value
GENESYS • Information Technology
Current Stock Price
₹234.18
Primary Intrinsic Value
₹138.72
Market Cap
₹468.4 Cr
-40.8%
Downside
Median Value
₹138.72
Value Range
₹74 - ₹408
Assessment
Trading Above Calculated Value
Safety Margin
-68.8%
GENESYS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹138.72 | ₹110.98 - ₹166.46 | -40.8% | EPS: ₹11.56, Sector P/E: 12x |
| Book Value Method | asset | ₹278.50 | ₹250.65 - ₹306.35 | +18.9% | Book Value/Share: ₹278.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹129.60 | ₹116.64 - ₹142.56 | -44.7% | Revenue/Share: ₹162.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹408.00 | ₹367.20 - ₹448.80 | +74.2% | EBITDA: ₹136.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹93.67 | ₹74.94 - ₹112.40 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹73.98 | ₹66.58 - ₹81.38 | -68.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹95.25 | ₹85.73 - ₹104.78 | -59.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹240.00 | ₹216.00 - ₹264.00 | +2.5% | ROE: 8.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹269.14 | ₹242.23 - ₹296.05 | +14.9% | EPS: ₹11.56, BVPS: ₹278.50 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
GENESYS Intrinsic Value Analysis
What is the intrinsic value of GENESYS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Genesys International Corp (GENESYS) is ₹138.72 (median value). With the current market price of ₹234.18, this represents a -40.8% variance from our estimated fair value.
The valuation range spans from ₹73.98 to ₹408.00, indicating ₹73.98 - ₹408.00.
Is GENESYS undervalued or overvalued?
Based on our multi-method analysis, Genesys International Corp (GENESYS) appears to be trading above calculated value by approximately 40.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.22 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 39.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.42x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Genesys International Corp
Additional stock information and data for GENESYS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-53 Cr | ₹-62 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹19 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-35 Cr | ₹-130 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹28 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹19 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |